← Back to all trials
Completed
NCT06829498
BCAAs in Concussion 2.0
Conditions: Concussion, Brain, Concussion, Mild, Concussion
Sex: All
Ages: 11 Years – 23 Years
Healthy volunteers: No
Phase: PHASE2
Enrollment: 17
Sponsor: Akiva Cohen
Location: Children's Hospital of Philadelphia Philadelphia Pennsylvania
Summary
This study is a randomized, placebo-controlled, double-blinded, therapeutic exploratory clinical trial of branched chain amino acids (BCAAs) in the treatment of concussion. The aim of the study is to determine whether administration of high-dose BCAAs compared to placebo promotes concussion recovery.
Eligibility Criteria
Inclusion Criteria:
1. Males and females,11 - 23 years of age.
2. Weigh at least 40kg.
3. Meeting concussion criteria for the American Congress of Rehabilitative Medicine.
4. Present within 4 days of injury.
5. Post-menarchal females must have a negative urine pregnancy test and must use an acceptable method of contraception.
6. Informed consent by the participant, or for participants \
Source: ClinicalTrials.gov (NCT06829498). StuddyBuddy aggregates publicly available trial information.
